FDA Inspection 1206061 - Konrad Rejdak, M.D., Ph.D. - May 19, 2023

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns Konrad Rejdak, M.D., Ph.D., with an inspection on May 19, 2023, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Konrad Rejdak, M.D., Ph.D.
Inspection Date: May 19, 2023
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 11a37c52-0af4-4ca9-ae20-1862fc12e96e

Violation Codes1

21 CFR 312.62(b)

Full citation text and observation details available on the Dashboard.